ArticleJACC. Case reports2026
Staged Cesarean and Cardiac Surgery for Recurrent Left Atrial Myxofibrosarcoma in Pregnancy.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When Recurrent Myxoma Is Not a Myxoma: Reclassification and Recurrence in Cardiac Myxofibrosarcoma.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac surgery in late pregnancy requires balancing maternal rescue against fetal risk. CASE SUMMARY: A 31-week pregnant woman with prior resection of a left atrial "myxoma" presented with acute heart failure caused by recurrent masses prolapsing through the mitral valve. Because the fetus was viable and maternal collapse was imminent, a 7-F, 35-mL intra-aortic balloon pump was inserted, cesarean delivery was performed, and redo open-heart surgery followed the next day. A 1,638-g male infant with Apgar scores of 7 and 8 was delivered. Two posterior left atrial tumors were resected; one involved the mitral leaflet and required mechanical mitral valve replacement. Re-review of the recurrent and original specimens showed morphology and immunophenotype consistent with myxofibrosarcoma. DISCUSSION: Staged delivery before cardiopulmonary bypass can protect a viable fetus in hemodynamically critical maternal disease. TAKE-HOME MESSAGE: Pathological re-evaluation is essential when "recurrent myxoma" behaves atypically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.